These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

354 related articles for article (PubMed ID: 32521135)

  • 1. Down Syndrome.
    Bull MJ
    N Engl J Med; 2020 Jun; 382(24):2344-2352. PubMed ID: 32521135
    [No Abstract]   [Full Text] [Related]  

  • 2. "Down syndrome: an insight of the disease".
    Asim A; Kumar A; Muthuswamy S; Jain S; Agarwal S
    J Biomed Sci; 2015 Jun; 22(1):41. PubMed ID: 26062604
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rethinking second-trimester Down-syndrome screening in the cell-free DNA era.
    Cuckle H
    Ultrasound Obstet Gynecol; 2019 Oct; 54(4):431-436. PubMed ID: 31140633
    [No Abstract]   [Full Text] [Related]  

  • 4. [Prenatal ultrasonic diagnosis of a developmental heart defect and Down syndrome].
    Intödy Z; Hajdú K; Fantoli L; Arató G; László J
    Orv Hetil; 1985 Dec; 126(52):3207-9. PubMed ID: 2934678
    [No Abstract]   [Full Text] [Related]  

  • 5. International Society for Prenatal Diagnosis Position Statement: cell free (cf)DNA screening for Down syndrome in multiple pregnancies.
    Palomaki GE; Chiu RWK; Pertile MD; Sistermans EA; Yaron Y; Vermeesch JR; Vora NL; Best RG; Wilkins-Haug L
    Prenat Diagn; 2021 Sep; 41(10):1222-1232. PubMed ID: 33016373
    [No Abstract]   [Full Text] [Related]  

  • 6. Have we done our last amniocentesis? Updates on cell-free DNA for Down syndrome screening.
    Gray KJ; Wilkins-Haug LE
    Pediatr Radiol; 2018 Apr; 48(4):461-470. PubMed ID: 29550862
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Down-Klinefelter syndrome (48,XXY,+21) in a child with congenital heart disease: case report and literature review.
    Shen Z; Zou CC; Shang SQ; Jiang KW
    Intern Med; 2012; 51(11):1371-4. PubMed ID: 22687844
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Down-Klinefelter syndrome (48,XXY,+21) in a neonate associated with congenital heart disease.
    Rodrigues MA; Morgade LF; Dias LFA; Moreira RV; Maia PD; Sales AFH; Ribeiro PD
    Genet Mol Res; 2017 Sep; 16(3):. PubMed ID: 28973759
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Correlation between Z score, fetal fraction, and sequencing reads in non-invasive prenatal testing.
    Balslev-Harder M; Richter SR; Kjaergaard S; Johansen P
    Prenat Diagn; 2017 Sep; 37(9):943-945. PubMed ID: 28726258
    [No Abstract]   [Full Text] [Related]  

  • 10. Two cases of placental T21 mosaicism: challenging the detection limits of non-invasive prenatal testing.
    Wang Y; Zhu J; Chen Y; Lu S; Chen B; Zhao X; Wu Y; Han X; Ma D; Liu Z; Cram D; Cheng W
    Prenat Diagn; 2013 Dec; 33(12):1207-10. PubMed ID: 23929588
    [No Abstract]   [Full Text] [Related]  

  • 11. [Congenital heart disease and down syndrome (author's transl)].
    Cyhlar MM; Wimmer M
    Padiatr Padol; 1976; 11(1):254-60. PubMed ID: 129755
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Performance of semiconductor sequencing platform for non-invasive prenatal genetic screening for fetal aneuploidy: results from a multicenter prospective cohort study in a clinical setting.
    El Khattabi LA; Brun S; Gueguen P; Chatron N; Guichoux E; Schutz S; Nectoux J; Sorlin A; Quere M; Boudjarane J; Tsatsaris V; Mandelbrot L; Schluth-Bolard C; Dupont JM; Rooryck C;
    Ultrasound Obstet Gynecol; 2019 Aug; 54(2):246-254. PubMed ID: 30191619
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neonatal complications of Down syndrome and factors necessitating intensive care.
    Seither K; Tabbah S; Tadesse DG; Suhrie KR
    Am J Med Genet A; 2021 Feb; 185(2):336-343. PubMed ID: 33128508
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cell-free fetal DNA testing in singleton IVF conceptions.
    Lee TJ; Rolnik DL; Menezes MA; McLennan AC; da Silva Costa F
    Hum Reprod; 2018 Apr; 33(4):572-578. PubMed ID: 29462319
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Concerns following rapid implementation of first-line screening for aneuploidy by cell-free DNA analysis in the Belgian healthcare system.
    Abousleiman C; Lismonde A; Jani JC
    Ultrasound Obstet Gynecol; 2019 Jun; 53(6):847-848. PubMed ID: 30937993
    [No Abstract]   [Full Text] [Related]  

  • 16. cfDNA screening performance: accounting for and reducing test failures.
    Cuckle H
    Ultrasound Obstet Gynecol; 2017 Jun; 49(6):689-692. PubMed ID: 28429561
    [No Abstract]   [Full Text] [Related]  

  • 17. Incorporating thyroid markers in Down syndrome screening protocols.
    Dhaifalah I; Salek T; Langova D; Cuckle H
    Prenat Diagn; 2017 May; 37(5):510-514. PubMed ID: 28374559
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Combining Effects of Cell-Free Circulating Tumor DNA of Breast Tumor to the Noninvasive Prenatal Testing Results: A Simulating Investigation.
    Cai YH; Yao GY; Chen LJ; Gan HY; Ye CS; Yang XX
    DNA Cell Biol; 2018 Jul; 37(7):626-633. PubMed ID: 29957029
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Trisomy 21. Epidemiology, diagnosis, disease outcome].
    Gay C
    Rev Prat; 1998 May; 48(9):999-1002. PubMed ID: 11767361
    [No Abstract]   [Full Text] [Related]  

  • 20. ISUOG updated consensus statement on the impact of cfDNA aneuploidy testing on screening policies and prenatal ultrasound practice.
    Salomon LJ; Alfirevic Z; Audibert F; Kagan KO; Paladini D; Yeo G; Raine-Fenning N;
    Ultrasound Obstet Gynecol; 2017 Jun; 49(6):815-816. PubMed ID: 28573775
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 18.